Clinical Trial Update: Botulinum Toxin Efficiency on Spasticity of Rectus Femoris and Semitendinosus Muscles as Functional Agonist and Antagonist Muscles [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial testing botulinum toxin for reducing spasticity in cerebral palsy, examining rectus femoris and semitendinosus muscles as functional agonist/anta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Cerebral Palsy | Phase 2, Phase 3 | Status: COMPLETED